Urinary Bladder Neoplasms
"Urinary Bladder Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the URINARY BLADDER.
| Descriptor ID |
D001749
|
| MeSH Number(s) |
C04.588.945.947.960 C12.758.820.968 C12.777.829.813 C13.351.937.820.945 C13.351.968.829.707
|
| Concept/Terms |
Urinary Bladder Neoplasms- Urinary Bladder Neoplasms
- Neoplasm, Urinary Bladder
- Urinary Bladder Neoplasm
- Neoplasms, Bladder
- Bladder Neoplasms
- Bladder Neoplasm
- Neoplasm, Bladder
- Bladder Tumors
- Bladder Tumor
- Tumor, Bladder
- Tumors, Bladder
Urinary Bladder Cancer- Urinary Bladder Cancer
- Cancer, Urinary Bladder
- Malignant Tumor of Urinary Bladder
- Cancer of the Bladder
- Bladder Cancer
- Bladder Cancers
- Cancer, Bladder
- Cancer of Bladder
|
Below are MeSH descriptors whose meaning is more general than "Urinary Bladder Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Urinary Bladder Neoplasms".
This graph shows the total number of publications written about "Urinary Bladder Neoplasms" by people in this website by year, and whether "Urinary Bladder Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 2 | 3 |
| 1996 | 2 | 0 | 2 |
| 1997 | 2 | 2 | 4 |
| 1998 | 2 | 1 | 3 |
| 1999 | 6 | 0 | 6 |
| 2000 | 7 | 1 | 8 |
| 2001 | 14 | 1 | 15 |
| 2002 | 9 | 0 | 9 |
| 2003 | 22 | 2 | 24 |
| 2004 | 15 | 2 | 17 |
| 2005 | 13 | 0 | 13 |
| 2006 | 26 | 1 | 27 |
| 2007 | 14 | 0 | 14 |
| 2008 | 26 | 0 | 26 |
| 2009 | 15 | 0 | 15 |
| 2010 | 18 | 2 | 20 |
| 2011 | 11 | 1 | 12 |
| 2012 | 11 | 1 | 12 |
| 2013 | 10 | 1 | 11 |
| 2014 | 16 | 0 | 16 |
| 2015 | 11 | 1 | 12 |
| 2016 | 17 | 0 | 17 |
| 2017 | 17 | 0 | 17 |
| 2018 | 9 | 0 | 9 |
| 2019 | 17 | 0 | 17 |
| 2020 | 14 | 1 | 15 |
| 2021 | 17 | 1 | 18 |
| 2022 | 10 | 0 | 10 |
| 2023 | 13 | 0 | 13 |
| 2024 | 19 | 2 | 21 |
| 2025 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Urinary Bladder Neoplasms" by people in Profiles.
-
Metabolic landscape in bladder cancer. Curr Opin Oncol. 2025 May 01; 37(3):259-266.
-
Development of TAR-200: A novel targeted releasing system designed to provide sustained delivery of gemcitabine for patients with bladder cancer. Urol Oncol. 2025 May; 43(5):286-296.
-
Integrating gene therapy into the treatment paradigm for non-muscle invasive bladder cancer. Expert Opin Biol Ther. 2025 Jan-Feb; 25(2):149-159.
-
Concomitant antihistamine administration is associated with improved survival outcomes in patients with locally advanced or metastatic urothelial carcinoma treated with atezolizumab. Analysis of individual participant data from IMvigor210 and IMvigor211. Urol Oncol. 2025 Mar; 43(3):188.e9-188.e17.
-
The Financial Burden of Localized and Metastatic Bladder Cancer. Eur Urol. 2025 May; 87(5):536-550.
-
Enhanced Recovery After Surgery for patients undergoing radical cystectomy: Surgeons' perspectives and recommendations ten years after its implementation. Eur J Surg Oncol. 2025 Mar; 51(3):109543.
-
Oncologic Outcomes of Sequential Intravesical Gemcitabine and Docetaxel Compared with Bacillus Calmette-Gu?rin in Patients with Bacillus Calmette-Gu?rin-Unresponsive Non-Muscle Invasive Bladder Cancer. Eur Urol Oncol. 2025 Apr; 8(2):469-476.
-
Nectin-4 Positivity in Genitourinary Malignancies: A Systematic Review. JCO Precis Oncol. 2024 Dec; 8:e2400470.
-
Clinical Outcomes With Immune Checkpoint Inhibitors in Patients With FGFR2/3, MTAP or ERBB2 Genomic Alterations in Advanced Urothelial Carcinoma. Clin Genitourin Cancer. 2025 Feb; 23(1):102284.
-
Unmet Need in Non-muscle-invasive Bladder Cancer Failing Bacillus Calmette-Gu?rin Therapy: A Systematic Review and Cost-effectiveness Analyses from the International Bladder Cancer Group. Eur Urol Oncol. 2025 Feb; 8(1):216-229.